Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 11, 2020

SELL
$63.37 - $107.88 $6.98 Million - $11.9 Million
-110,195 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$96.94 - $113.59 $21.9 Million - $25.7 Million
-226,364 Reduced 67.26%
110,195 $11.5 Million
Q3 2019

Nov 04, 2019

BUY
$86.25 - $120.16 $855,082 - $1.19 Million
9,914 Added 3.04%
336,559 $33.5 Million
Q2 2019

Aug 05, 2019

SELL
$107.38 - $129.34 $62,924 - $75,793
-586 Reduced 0.18%
326,645 $37.3 Million
Q1 2019

May 01, 2019

SELL
$105.93 - $142.47 $12.3 Million - $16.5 Million
-116,045 Reduced 26.18%
327,231 $41.1 Million
Q4 2018

Feb 11, 2019

BUY
$128.36 - $272.13 $5.2 Million - $11 Million
40,527 Added 10.06%
443,276 $60.2 Million
Q3 2018

Nov 08, 2018

SELL
$211.18 - $274.49 $4.12 Million - $5.35 Million
-19,497 Reduced 4.62%
402,749 $111 Million
Q2 2018

Aug 07, 2018

SELL
$150.77 - $207.98 $2.08 Million - $2.87 Million
-13,780 Reduced 3.16%
422,246 $87.5 Million
Q1 2018

May 09, 2018

SELL
$138.63 - $182.62 $2.59 Million - $3.42 Million
-18,718 Reduced 4.12%
436,026 $72 Million
Q4 2017

Feb 09, 2018

SELL
$128.36 - $147.04 $4.44 Million - $5.08 Million
-34,570 Reduced 7.06%
454,744 $62.5 Million
Q3 2017

Nov 09, 2017

BUY
$120.91 - $137.94 $59.2 Million - $67.5 Million
489,314
489,314 $66.6 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.